blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2191015

EP2191015 - A METHOD FOR PREDICTING THE RESPONSE OF A TUMOR IN A PATIENT SUFFERING FROM OR AT RISK OF DEVELOPING RECURRENT GYNECOLOGIC CANCER TOWARDS A CHEMOTHERAPEUTIC AGENT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.09.2011
Database last updated on 24.08.2024
Most recent event   Tooltip30.09.2011Application deemed to be withdrawnpublished on 02.11.2011  [2011/44]
Applicant(s)For all designated states
Sividon Diagnostics GmbH
Nattermann Allee 1
50829 Köln / DE
[2011/24]
Former [2010/22]For all designated states
Siemens Healthcare Diagnostics GmbH
Ludwig-Erhard-Strasse 12
65760 Eschborn / DE
Inventor(s)01 / GEHRMANN, Mathias
Schlebuscher Heide 13
51375 Leverkusen / DE
02 / BRASE, Jan Christoph
Kastanienallee 16a
21255 Tostedt / DE
03 / SCHMIDT, Marcus
Eleonorenstr. 28
55252 Mainz-kastel / DE
 [2010/22]
Representative(s)Meyers, Hans-Wilhelm, et al
Von Kreisler Selting Werner
ATTENTION : ADDRESS INACTIVE - USE ASS-NR - CDR / DE
[N/P]
Former [2011/24]Meyers, Hans-Wilhelm, et al
Von Kreisler Selting Werner P.O. BOX 102241
50462 Köln / DE
Former [2010/22]Maier, Daniel Oliver
Siemens AG CT IP Com E Postfach 22 16 34
80506 München / DE
Application number, filing date08787449.125.08.2008
[2010/22]
WO2008EP61088
Priority number, dateDE2007104345512.09.2007         Original published format: DE102007043455
EP2007012291911.12.2007         Original published format: EP 07122919
[2010/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009033941
Date:19.03.2009
Language:EN
[2009/12]
Type: A1 Application with search report 
No.:EP2191015
Date:02.06.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 19.03.2009 takes the place of the publication of the European patent application.
[2010/22]
Search report(s)International search report - published on:EP19.03.2009
ClassificationIPC:C12Q1/68
[2010/22]
CPC:
C12Q1/6886 (EP,US); C12Q2600/106 (EP,US); C12Q2600/112 (EP,US);
C12Q2600/158 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/22]
TitleGerman:VERFAHREN ZUR VORHERSAGE DES ANSPRECHENS EINES TUMORS AUF EIN CHEMOTHERAPEUTIKUM BEI EINEM PATIENTEN MIT EINER WIEDER AUFTRETENDEN GYNÄKOLOGISCHEN KREBSERKRANKUNG ODER DEM RISIKO DER ENTWICKLUNG DAVON[2010/22]
English:A METHOD FOR PREDICTING THE RESPONSE OF A TUMOR IN A PATIENT SUFFERING FROM OR AT RISK OF DEVELOPING RECURRENT GYNECOLOGIC CANCER TOWARDS A CHEMOTHERAPEUTIC AGENT[2010/22]
French:PROCÉDÉ DE PRÉVISION DE LA RÉPONSE D'UNE TUMEUR À UN AGENT CHIMIOTHÉRAPEUTIQUE CHEZ UN PATIENT SOUFFRANT D'UN CANCER GYNÉCOLOGIQUE RÉCURRENT OU À RISQUE DE DÉVELOPPER UN CANCER GYNÉCOLOGIQUE RÉCURRENT[2010/22]
Entry into regional phase15.03.2010National basic fee paid 
15.03.2010Designation fee(s) paid 
15.03.2010Examination fee paid 
Examination procedure15.03.2010Examination requested  [2010/22]
25.05.2010Amendment by applicant (claims and/or description)
26.10.2010Despatch of a communication from the examining division (Time limit: M06)
06.05.2011Application deemed to be withdrawn, date of legal effect  [2011/44]
10.06.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/44]
Divisional application(s)EP11164981.0  / EP2390370
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  26.10.2010
Fees paidRenewal fee
20.08.2010Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2005033699  (NCC TECHNOLOGY VENTURES PTE LT [SG], et al) [X] 2-10,15 * abstract *;
 [XY]  - SORLIE T, "Molecular portraits of breast cancer: tumour subtypes as distinct disease entities", EUROPEAN JOURNAL OF CANCER, PERGAMON PRESS, OXFORD, GB, (200412), vol. 40, no. 18, ISSN 0959-8049, pages 2667 - 2675, XP004661394 [X] 2-10,15 * abstract, chap. 3 on p. 2268-2669 and fig. 2, Chap 5. p. 2669-p. 2671, col. 1 and chap. 7 * [Y] 1,12

DOI:   http://dx.doi.org/10.1016/j.ejca.2004.08.021
 [X]  - DRESSMAN HOLLY K ET AL, "Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 1 FEB 2006, (20060201), vol. 12, no. 3 Pt 1, ISSN 1078-0432, pages 819 - 826, XP002472390 [X] 2-10,15 * abstract, Tab. 2 and 4 *

DOI:   http://dx.doi.org/10.1158/1078-0432.CCR-05-1447
 [X]  - ROUZIER ROMAN ET AL, "Breast cancer molecular subtypes respond differently to preoperative chemotherapy.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 15 AUG 2005, (20050815), vol. 11, no. 16, ISSN 1078-0432, pages 5678 - 5685, XP002472391 [X] 2-10,15 * abstract, p. 5679, col. 1 and p. 5680, col. 1 *

DOI:   http://dx.doi.org/10.1158/1078-0432.CCR-04-2421
 [XY]  - LEWIS MICHAEL J ET AL, "Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma", BMC CANCER, BIOMED CENTRAL, LONDON, GB, (20040622), vol. 4, no. 1, ISSN 1471-2407, page 27, XP021004625 [X] 11,13,14,16-18 * abstract * [Y] 1,12

DOI:   http://dx.doi.org/10.1186/1471-2407-4-27
 [XY]  - WIEBE JOHN P ET AL, "Activity and expression of progesterone metabolizing 5[alpha]-reductase, 20[alpha]-hydroxysteroid oxidoreductase and 3[alpha]([beta])-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells", BMC CANCER, BIOMED CENTRAL, LONDON, GB, (20030322), vol. 3, no. 1, ISSN 1471-2407, page 9, XP021016085 [X] 11,13,14,16-18 * abstract, p. 4 and tab. 1 * [Y] 1,12

DOI:   http://dx.doi.org/10.1186/1471-2407-3-9
 [A]  - BRENTON JAMES D ET AL, "Molecular classification and molecular forecasting of breast cancer: ready for clinical application?", JOURNAL OF CLINICAL ONCOLOGY, GRUNE AND STRATTON, NEW YORK, NY, US, (200510), vol. 23, no. 29, ISSN 0732-183X, pages 7350 - 7360, XP009096987 [A] 1-18 * page 7355; figure 2 *

DOI:   http://dx.doi.org/10.1200/JCO.2005.03.3845
 [A]  - SEEBACH J ET AL, "A Molecular Profiling of Breast Cancer", SEMINARS IN BREAST DISEASE, SAUNDERS, PHILADELPHIA, PA, US, (2006), vol. 9, no. 1, ISSN 1092-4450, pages 19 - 24, XP009096977 [A] 1-18 * abstract, p. 20, cap. "breast cancer subtype" and p. 22, chap. "using gene signatures as a clinical tool" *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.